A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China

NCT06666855 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

345

Enrollment

INDUSTRY

Sponsor class

Conditions

Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: DE-117B Eye Drops
DRUG: Latanoprost

Sponsor

Santen Pharmaceutical Co., Ltd.